{"disease":{"id":"obsessive-compulsive-disorder","name":"Obsessive-compulsive disorder","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"fluoxetine","indication_name":"Obsessive-compulsive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prozac","generic_name":"fluoxetine","company_name":"Eli Lilly and Company","drug_phase":"marketed","molecular_target":"Serotonin reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":81,"revenue":"1000.0","mechanism":"Fluoxetine inhibits CNS neuronal uptake of serotonin, though exact mechanism unknown."},{"drug_id":"sertraline","indication_name":"Obsessive-compulsive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zoloft","generic_name":"sertraline","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A","drug_class":"SSRI (Selective serotonin reuptake inhibitor)","quality_score":71,"revenue":"350","mechanism":"Selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter, increasing synaptic serotonin to improve mood and reduce anxiety."},{"drug_id":"paroxetine","indication_name":"Obsessive Compulsive Disorder (OCD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Paroxetine","generic_name":"paroxetine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Serotonin (5-HT) reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":73,"revenue":null,"mechanism":"Inhibits neuronal reuptake of serotonin in the central nervous system, presumed mechanism for treating psychiatric disorders."},{"drug_id":"sertralin","indication_name":"Obsessive-compulsive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sertralin","company_name":"Poznan University of Medical Sciences","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluvoxamine","indication_name":"Obsessive Compulsive Disorder (OCD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Luvox","generic_name":"FLUVOXAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium-dependent serotonin transporter","drug_class":"Serotonin Reuptake Inhibitor","quality_score":75,"revenue":null,"mechanism":"Luvox works by blocking the reabsorption of serotonin in the brain, allowing more of this neurotransmitter to be available for communication between nerve cells."},{"drug_id":"clomipramine","indication_name":"Obsessive-compulsive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anafranil","generic_name":"CLOMIPRAMINE","company_name":"Specgx Llc","drug_phase":"marketed","molecular_target":"Sodium-dependent serotonin transporter","drug_class":"Tricyclic Antidepressant","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fluvoxamine","indication_name":"Obsessive-compulsive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Luvox","generic_name":"FLUVOXAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium-dependent serotonin transporter","drug_class":"Serotonin Reuptake Inhibitor","quality_score":75,"revenue":null,"mechanism":"Luvox works by blocking the reabsorption of serotonin in the brain, allowing more of this neurotransmitter to be available for communication between nerve cells."},{"drug_id":"prozac","indication_name":"Obsessive-compulsive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prozac","company_name":"RenJi Hospital","drug_phase":"marketed","molecular_target":"Equilibrative nucleoside transporter 4, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl809","indication_name":"Obsessive-Compulsive Disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SERTRALINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT07129408","title":"Epidemiological Study on the Prevalence of Mental Disorders in Slovakia","phase":"","overall_status":"COMPLETED","enrollment_count":3100,"lead_sponsor_name":"Comenius University","has_results":false},{"nct_id":"NCT06466447","title":"Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":2173,"lead_sponsor_name":"NOCD","has_results":false},{"nct_id":"NCT04701372","title":"Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention","phase":"","overall_status":"COMPLETED","enrollment_count":2069,"lead_sponsor_name":"NOCD","has_results":false},{"nct_id":"NCT05961306","title":"Diagnostic Accuracy of the Stepped Screening Protocol and Its Screening Tools in the Perinatal Period.","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT04539951","title":"Pragmatic Trial of Obsessive-compulsive Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT04900064","title":"Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1242,"lead_sponsor_name":"Linnaeus University","has_results":false},{"nct_id":"NCT04631042","title":"Developing Brain, Impulsivity and Compulsivity","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT06705179","title":"Can Computational Measures of Task Performance Predict Psychiatric Symptoms and Changes in Symptom Severity Across Time","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1100,"lead_sponsor_name":"California Institute of Technology","has_results":false},{"nct_id":"NCT00001548","title":"Genetics of Obsessive-Compulsive Disorder","phase":"","overall_status":"COMPLETED","enrollment_count":1067,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT01302080","title":"Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)","phase":"","overall_status":"COMPLETED","enrollment_count":941,"lead_sponsor_name":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","has_results":true},{"nct_id":"NCT04209296","title":"Chart Review of Patients Undergoing Ketamine Infusions","phase":"","overall_status":"COMPLETED","enrollment_count":891,"lead_sponsor_name":"Brain and Cognition Discovery Foundation","has_results":false},{"nct_id":"NCT04708834","title":"Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":772,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04723485","title":"Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood","phase":"","overall_status":"RECRUITING","enrollment_count":625,"lead_sponsor_name":"Susanne Walitza","has_results":false},{"nct_id":"NCT05467683","title":"CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT04693351","title":"Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":589,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06934525","title":"Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings","phase":"NA","overall_status":"RECRUITING","enrollment_count":501,"lead_sponsor_name":"Bradley Hospital","has_results":false},{"nct_id":"NCT05663489","title":"Neurobiological Markers of Treatment Response for Anxiety and OCD","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT04641143","title":"Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03299166","title":"Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":426,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT00004550","title":"Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT05651295","title":"A Precision Medicine Approach to Target Engagement for Emotion Regulation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":390,"lead_sponsor_name":"Matthew Southward","has_results":false},{"nct_id":"NCT03528109","title":"Improving Access to Child Anxiety Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":379,"lead_sponsor_name":"Bradley Hospital","has_results":false},{"nct_id":"NCT07452835","title":"Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT06370559","title":"Relationship Between Repetitive Negative Thinking and CBT Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"South London and Maudsley NHS Foundation Trust","has_results":false},{"nct_id":"NCT03451409","title":"Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder","phase":"","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT03113175","title":"Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Amager Hospital","has_results":false},{"nct_id":"NCT07092826","title":"Obsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum Disorders","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Matteo Tonna","has_results":false},{"nct_id":"NCT06110702","title":"Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT03993535","title":"Predicting Treatment Response in Patients With OCD","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT04335175","title":"Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder","phase":"","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT03929081","title":"Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"GGZ Centraal","has_results":false},{"nct_id":"NCT05712057","title":"Neurostimulation Versus Therapy for Problems With Emotions","phase":"NA","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06566781","title":"Reinforcement Learning and Obsessive-compulsive Disorder: Exploring the Role of the Orbitofrontal Cortex","phase":"","overall_status":"RECRUITING","enrollment_count":230,"lead_sponsor_name":"Fundacao Champalimaud","has_results":false},{"nct_id":"NCT04777292","title":"ESTOCMA: Mental Health Application for Enhancing Mental Health Literacy About Obsessive-compulsive Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":228,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT06202677","title":"Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":225,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT05829681","title":"Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":212,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT06616350","title":"Impact of EsTOCma on OCD Family Members","phase":"NA","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT02437773","title":"Neurocircuit Mechanisms of OCD Across the Lifespan","phase":"NA","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT04580043","title":"Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors","phase":"NA","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"Rebecca Price","has_results":false},{"nct_id":"NCT05609916","title":"CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT02431845","title":"Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Severance Hospital","has_results":false},{"nct_id":"NCT06262464","title":"An OCD Prevention Programme for at Risk Adults","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Babes-Bolyai University","has_results":false},{"nct_id":"NCT06834217","title":"Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT06376734","title":"Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04286126","title":"Neuroimaging Biomarkers for Predicting rTMS Response in OCD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03852186","title":"Towards Personalized Medicine for OCD","phase":"NA","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT07429500","title":"tDCS and Symptom Provocation in Treatment-Resistant OCD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":178,"lead_sponsor_name":"Centre Hospitalier Henri Laborit","has_results":false},{"nct_id":"NCT06334887","title":"esTOCma, an App Used by Teachers: an RCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"University of Valencia","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}